Cargando…

Impact of IL-1β and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance

Interleukin-1 beta (IL-1β), a pro-inflammatory cytokine, has been ascribed a role in the expansion of myeloid progenitors in acute myeloid leukemia (AML) and in promoting myeloid cell-induced suppression of lymphocyte-mediated immunity against malignant cells. This study aimed at defining the potent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grauers Wiktorin, Hanna, Aydin, Ebru, Christenson, Karin, Issdisai, Nuttida, Thorén, Fredrik B., Hellstrand, Kristoffer, Martner, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317920/ https://www.ncbi.nlm.nih.gov/pubmed/34367728 http://dx.doi.org/10.1080/2162402X.2021.1944538

Ejemplares similares

NOX2-Derived Reactive Oxygen Species in Cancer
por: Grauers Wiktorin, Hanna, et al.
Publicado: (2020)

COVID-19 vaccine-induced adverse events predict immunogenicity among recipients of allogeneic hematopoietic stem cell transplantation
por: Wiktorin, Hanna Grauers, et al.
Publicado: (2022)

NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance
por: Martner, Anna, et al.
Publicado: (2015)

NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease
por: Aydin, Ebru, et al.
Publicado: (2018)

Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2
por: Kiffin, Roberta, et al.
Publicado: (2018)

Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
por: Nilsson, Malin S., et al.
Publicado: (2019)

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia
por: Nilsson, Malin S., et al.
Publicado: (2019)

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
por: Grauers Wiktorin, Hanna, et al.
Publicado: (2018)

An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis
por: Arabpour, Mohammad, et al.
Publicado: (2022)

Induction and subsequent decline of S1-specific T cell reactivity after COVID-19 vaccination
por: Törnell, Andreas, et al.
Publicado: (2023)

NOX2 in autoimmunity, tumor growth and metastasis
por: Martner, Anna, et al.
Publicado: (2018)

Transient and durable T cell reactivity after COVID-19
por: Martner, Anna, et al.
Publicado: (2022)

Mutated NPM1 in combination with overexpression of Meis1 or Hoxa9 is not sufficient to induce acute myeloid leukemia
por: Wiktorin, Hanna Grauers, et al.
Publicado: (2016)

Rapid Cytokine Release Assays for Analysis of Severe Acute Respiratory Syndrome Coronavirus 2–Specific T Cells in Whole Blood
por: Törnell, Andreas, et al.
Publicado: (2022)

Presence of MDSC associates with impaired antigen-specific T cell reactivity following COVID-19 vaccination in cirrhotic patients
por: Törnell, Andreas, et al.
Publicado: (2023)

Role of the ERK Pathway for Oxidant-Induced Parthanatos in Human Lymphocytes
por: Akhiani, Ali A., et al.
Publicado: (2014)

Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation
por: Einarsdottir, Sigrun, et al.
Publicado: (2022)

Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
por: Hussein, Brwa Ali, et al.
Publicado: (2022)

Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
por: Hussein, Brwa Ali, et al.
Publicado: (2021)

Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination
por: Al-Dury, Samer, et al.
Publicado: (2022)

Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia
por: Martner, Anna, et al.
Publicado: (2015)

Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells
por: Werlenius, Olle, et al.
Publicado: (2016)

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells
por: Hussein, Brwa Ali, et al.
Publicado: (2023)

Urinary excretion of IL-1β, IL-6 and IL-8 cytokines during relapse and remission of idiopathic nephrotic syndrome
por: Al-Eisa, Amal A, et al.
Publicado: (2017)

Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis
por: Johansson, Junko, et al.
Publicado: (2019)

Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
por: Sander, Frida Ewald, et al.
Publicado: (2017)

IL-1 Receptor Antagonist (IL-1Ra) Levels and Management of Metabolic Disorders
por: Luotola, Kari
Publicado: (2022)

IL1RAP potentiates multiple oncogenic signaling pathways in AML
por: Mitchell, Kelly, et al.
Publicado: (2018)

Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia
por: Sander, Frida Ewald, et al.
Publicado: (2016)

Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis
por: Wilkinson, Robert J., et al.
Publicado: (1999)

IL-1 Receptor Antagonist Reduced Chemical-Induced Keratinocyte Apoptosis through Antagonism to IL-1α/IL-1β
por: Lee, Hyejin, et al.
Publicado: (2018)

IL-25 exacerbates autoimmune aortitis in IL-1 receptor antagonist-deficient mice
por: Yoshizaki, Takamichi, et al.
Publicado: (2019)

The antagonistic duality of NPM1 mutations in AML
por: Khan, Irum, et al.
Publicado: (2022)

HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia
por: Komic, Hana, et al.
Publicado: (2023)

Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity
por: Einarsdottir, Sigrun, et al.
Publicado: (2022)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6
por: Liao, Liping, et al.
Publicado: (2022)

Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion
por: Horai, Reiko, et al.
Publicado: (1998)

IL-1 Family Antagonists in Mouse and Human Skin Inflammation
por: Martin, Praxedis, et al.
Publicado: (2021)

Maintenance Therapy in AML
por: Reville, Patrick K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d3g1m4epn9mohcgs54j8qt877f